dc.contributor.author | ARINCI, A | |
dc.contributor.author | TOPALAN, M | |
dc.contributor.author | GUVENC, H | |
dc.contributor.author | ERER, M | |
dc.date.accessioned | 2021-03-04T09:39:38Z | |
dc.date.available | 2021-03-04T09:39:38Z | |
dc.date.issued | 1993 | |
dc.identifier.citation | TOPALAN M., ARINCI A., ERER M., GUVENC H., "THE EFFECT OF PARENTERAL PENTOXIFYLLINE THERAPY ON SKIN FLAP SURVIVAL", EUROPEAN JOURNAL OF PLASTIC SURGERY, cilt.16, sa.1, ss.33-35, 1993 | |
dc.identifier.issn | 0930-343X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_6947db8e-1b58-44c2-8cbd-88f18e0e6cb0 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/72953 | |
dc.identifier.uri | https://doi.org/10.1007/bf00192704 | |
dc.description.abstract | The effect of pentoxifylline as a hemorrheologic agent on skin flap survival has been observed. A caudally pedicled dorsal flap with an ischemic component in rats was used as the model. The flap survival was calculated to be 0.807+/-0.049 in the control group (n = 15), where flap survival was found to be 0.9713+/-0.018 in the pentoxifylline treated group (n = 15) (t = 12.19, p < 0.005). In the meantime, living flap length was measured as 9.96+/-0.72 in the control group, and 11.84+/-0.18 in the pentoxifylline treated group. With these results, we have come to the conclusion that parenteral pentoxifylline therapy is effective on ischemic skin flap survival in the rat model. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | CERRAHİ | |
dc.title | THE EFFECT OF PARENTERAL PENTOXIFYLLINE THERAPY ON SKIN FLAP SURVIVAL | |
dc.type | Makale | |
dc.relation.journal | EUROPEAN JOURNAL OF PLASTIC SURGERY | |
dc.contributor.department | , , | |
dc.identifier.volume | 16 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 33 | |
dc.identifier.endpage | 35 | |
dc.contributor.firstauthorID | 113961 | |